BSE Live
Apr 10, 16:01Prev. Close
157.75
Open Price
156.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Makers Laboratories (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 6.44 | 5.49 | -0.47 | 2.00 | 0.49 | |
| Diluted EPS (Rs.) | 6.44 | 5.49 | -0.47 | 2.00 | 0.49 | |
| Cash EPS (Rs.) | 6.85 | 5.79 | 0.19 | 3.05 | 1.64 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 32.51 | 27.24 | 21.75 | 22.26 | 20.49 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 32.51 | 27.24 | 21.75 | 22.26 | 20.49 | |
| Dividend / Share(Rs.) | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 110.61 | 101.21 | 115.26 | 107.33 | 82.52 | |
| PBDIT/Share (Rs.) | 12.54 | 9.85 | 5.88 | 5.70 | 3.37 | |
| PBIT/Share (Rs.) | 12.13 | 9.55 | 5.23 | 4.65 | 2.22 | |
| PBT/Share (Rs.) | 10.68 | 8.39 | 3.87 | 3.17 | 0.82 | |
| Net Profit/Share (Rs.) | 6.44 | 5.49 | -0.47 | 2.00 | 0.49 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 11.34 | 9.73 | 5.10 | 5.30 | 4.08 | |
| PBIT Margin (%) | 10.96 | 9.43 | 4.53 | 4.32 | 2.69 | |
| PBT Margin (%) | 9.65 | 8.28 | 3.35 | 2.95 | 0.99 | |
| Net Profit Margin (%) | 5.81 | 5.42 | -0.40 | 1.86 | 0.59 | |
| Return on Networth / Equity (%) | 19.80 | 20.15 | -2.15 | 8.98 | 2.39 | |
| Return on Capital Employed (%) | 16.91 | 19.58 | -2.06 | 7.43 | 1.93 | |
| Return on Assets (%) | 9.12 | 10.18 | -1.11 | 4.13 | 1.07 | |
| Total Debt/Equity (X) | 0.75 | 0.55 | 0.35 | 0.74 | 0.68 | |
| Asset Turnover Ratio (%) | 156.80 | 187.79 | 274.01 | 221.75 | 181.31 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.41 | 1.30 | 1.58 | 1.36 | 1.44 | |
| Quick Ratio (X) | 0.85 | 0.69 | 0.86 | 0.62 | 0.69 | |
| Inventory Turnover Ratio (X) | 6.17 | 6.39 | 8.34 | 6.73 | 5.49 | |
| Dividend Payout Ratio (NP) (%) | 15.53 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 14.59 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 84.47 | 100.00 | 0.00 | 100.00 | 100.00 | |
| Cash Earnings Retention Ratio (%) | 85.41 | 100.00 | 0.00 | 100.00 | 100.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 28.26 | 11.57 | 8.72 | 14.77 | 13.49 | |
| EV/Net Operating Revenue (X) | 0.59 | 0.26 | 0.17 | 0.32 | 0.38 | |
| EV/EBITDA (X) | 5.18 | 2.70 | 3.41 | 5.96 | 9.21 | |
| MarketCap/Net Operating Revenue (X) | 0.37 | 0.12 | 0.11 | 0.17 | 0.21 | |
| Retention Ratios (%) | 84.46 | 100.00 | 0.00 | 100.00 | 100.00 | |
| Price/BV (X) | 1.26 | 0.43 | 0.59 | 0.80 | 0.86 | |
| Price/Net Operating Revenue | 0.37 | 0.12 | 0.11 | 0.17 | 0.21 | |
| Earnings Yield | 0.16 | 0.46 | -0.04 | 0.11 | 0.03 |
20.02.2026
Makers Labs Consolidated December 2025 Net Sales at Rs 35.67 crore, up 28.81% Y-o-Y
19.02.2026
Makers Labs Standalone December 2025 Net Sales at Rs 12.70 crore, up 34.43% Y-o-Y
14.11.2025
Makers Labs Consolidated September 2025 Net Sales at Rs 34.17 crore, up 15.58% Y-o-Y
12.11.2025
Makers Labs Standalone September 2025 Net Sales at Rs 12.64 crore, up 9.89% Y-o-Y
20.02.2026
Makers Labs Consolidated December 2025 Net Sales at Rs 35.67 crore, up 28.81% Y-o-Y
19.02.2026
Makers Labs Standalone December 2025 Net Sales at Rs 12.70 crore, up 34.43% Y-o-Y
14.11.2025
Makers Labs Consolidated September 2025 Net Sales at Rs 34.17 crore, up 15.58% Y-o-Y
12.11.2025
Makers Labs Standalone September 2025 Net Sales at Rs 12.64 crore, up 9.89% Y-o-Y
10.04.2026
09.04.2026
08.04.2026
Indian CDMOs face tariff exposure via patented drug supply chains
08.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth